Replimune (REPL) Capital Leases (2019 - 2026)
Replimune (REPL) posted Capital Leases of $21.69 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 3.8% from $22.54 million a year earlier and down 1.0% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Capital Leases (2019 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune's Capital Leases came in at $21.91 million, down 3.6% from FY2025.
- Annual Capital Leases has declined for six consecutive fiscal years, with a five-year compound annual growth rate of -2.4% (FY2021 to FY2026).
- In prior fiscal years, Replimune's Capital Leases was $22.73 million in FY2025 (-2.9%), $23.41 million in FY2024 (-2.3%), $23.97 million in FY2023 (-1.8%) and $24.41 million in FY2022 (-1.4%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Capital Leases since fiscal Q2 2020.
- On a year-over-year basis, Capital Leases has declined in each of the last 23 quarters, with an average decline of 3.2% over the last eight quarters.
- Across the past five years, year-over-year decline in Capital Leases ran from 1.2% in fiscal Q2 2022 to 3.8% in fiscal Q1 2027.
- According to Business Quant data, Capital Leases for the three prior fiscal quarters was $21.91 million (Q4 2026), $22.13 million (Q3 2026) and $22.34 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.15 Bn | 1,101.73 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.41 Bn | 534.94 Bn | 17.26 Bn |
| 3 | AbbVie | 501.01 Bn | 474.12 Bn | 12.70 Bn |
| 4 | Merck | 367.15 Bn | 321.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.00 Bn | 261.99 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.56 Bn | 235.25 Bn | 12.86 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn |
| 9 | Pfizer | 169.76 Bn | 116.40 Bn | 10.94 Bn |
| 10 | Replimune | 1.16 Bn | 104.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.69 Mn |
| Mar 31, 2026 | 21.91 Mn |
| Dec 31, 2025 | 22.13 Mn |
| Sep 30, 2025 | 22.34 Mn |
| Jun 30, 2025 | 22.54 Mn |
| Mar 31, 2025 | 22.73 Mn |
| Dec 31, 2024 | 22.91 Mn |
| Sep 30, 2024 | 23.09 Mn |
| Jun 30, 2024 | 23.26 Mn |
| Mar 31, 2024 | 23.41 Mn |
| Dec 31, 2023 | 23.56 Mn |
| Sep 30, 2023 | 23.71 Mn |
| Jun 30, 2023 | 23.84 Mn |
| Mar 31, 2023 | 23.97 Mn |
| Dec 31, 2022 | 24.09 Mn |
| Sep 30, 2022 | 24.21 Mn |
| Jun 30, 2022 | 24.31 Mn |
| Mar 31, 2022 | 24.41 Mn |
| Dec 31, 2021 | 24.50 Mn |
| Sep 30, 2021 | 24.59 Mn |
API Access
Replimune Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();